Anbio Biotechnology Ltd. (N3B)
Market Closed
17 Jul, 20:00
XDUS 
€
8. 10
+0.35
+4.5161%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 7.75
Previous Close Want to track N3B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anbio Biotechnology Ltd. (N3B) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) 159.18
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 43.89M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 7.75
52-Week high 43.6
Beta -
50-Day moving average 21.21
200-Day moving average 25.2
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.87%
Operating margin 0.67%
Operational effectiveness
Return on assets 0.21%
Return on equity 0.21%
Income Statement
Revenue (ttm) 8.65M
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) 7.54M
EBITDA 5.27M
Net income to common (ttm) 6.4M
Diluted EPS (ttm) 0.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 344.31%
Book value per share (mrq) -
Cash Flow
Cash flow statement 2.17M
Levered free cash flow (LFCF) 6.4M
